Henry Schein Inc. (NASDAQ:HSIC) shares were down 7.1% during trading on Thursday . The company traded as low as $163.27 and last traded at $166.98, with a volume of 1,069,012 shares changing hands. The stock had previously closed at $179.68.

A number of research analysts have recently commented on HSIC shares. Vetr lowered Henry Schein from a “buy” rating to a “hold” rating and set a $176.75 price objective on the stock. in a report on Monday, April 18th. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a report on Tuesday, July 5th. Leerink Swann reaffirmed a “hold” rating on shares of Henry Schein in a report on Thursday, May 5th. Barrington Research reaffirmed an “outperform” rating and issued a $188.00 target price (up previously from $182.00) on shares of Henry Schein in a report on Wednesday, May 4th. Finally, Credit Suisse Group AG reaffirmed a “hold” rating on shares of Henry Schein in a report on Saturday, June 4th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $155.37.

The stock has a market capitalization of $13.42 billion and a P/E ratio of 27.99. The company has a 50 day moving average price of $177.89 and a 200 day moving average price of $169.46.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Thursday, August 4th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.63 by $0.01. The firm earned $2.87 billion during the quarter, compared to the consensus estimate of $2.85 billion. During the same quarter last year, the firm earned $1.46 earnings per share. The business’s revenue for the quarter was up 9.3% on a year-over-year basis. Analysts expect that Henry Schein Inc. will post $6.63 earnings per share for the current fiscal year.

In related news, SVP James A. Harding sold 10,302 shares of the company’s stock in a transaction dated Monday, May 16th. The stock was sold at an average price of $172.60, for a total transaction of $1,778,125.20. Following the sale, the senior vice president now owns 21,933 shares in the company, valued at $3,785,635.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Gerald A. Benjamin sold 9,991 shares of the company’s stock in a transaction dated Thursday, June 2nd. The stock was sold at an average price of $175.08, for a total value of $1,749,224.28. Following the sale, the executive vice president now owns 54,885 shares in the company, valued at approximately $9,609,265.80. The disclosure for this sale can be found here.

A number of hedge funds recently added to or reduced their stakes in the company. Advantus Capital Management Inc raised its stake in Henry Schein by 2.8% in the fourth quarter. Advantus Capital Management Inc now owns 8,048 shares of the company’s stock valued at $1,273,000 after buying an additional 221 shares during the last quarter. Victory Capital Management Inc. raised its stake in Henry Schein by 18.8% in the fourth quarter. Victory Capital Management Inc. now owns 8,124 shares of the company’s stock valued at $1,285,000 after buying an additional 1,284 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. raised its stake in Henry Schein by 6.2% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. now owns 11,053 shares of the company’s stock valued at $1,748,000 after buying an additional 648 shares during the last quarter. Bronfman E.L. Rothschild L.P. bought a new stake in Henry Schein during the fourth quarter valued at about $2,086,000. Finally, Utah Retirement Systems raised its stake in Henry Schein by 0.7% in the fourth quarter. Utah Retirement Systems now owns 15,125 shares of the company’s stock valued at $2,393,000 after buying an additional 100 shares during the last quarter.

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.